[{"NetIncomeLoss_1_Q2_USD":-10016000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":54487000.0,"Depreciation_2_Q2_USD":216000.0,"ProceedsFromSaleOfShortTermInvestments_2_Q2_USD":1498000.0,"AccruedSalariesCurrentAndNoncurrent_0_Q2_USD":2271000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":562000.0,"AssetsCurrent_0_Q2_USD":98895000.0,"OperatingLeaseExpense_2_Q2_USD":366000.0,"OperatingLeaseExpense_1_Q2_USD":173000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":578000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":546000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":141000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":95000.0,"UnrecognizedTaxBenefits_0_Q2_USD":0.0,"CommonStockSharesIssued_0_Q2_shares":62172418.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":42449000.0,"Assets_0_Q2_USD":101673000.0,"ShareBasedCompensation_2_Q2_USD":2717000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":2414000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":705000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":580000.0,"PaymentsForRestructuring_1_Q2_USD":69000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":130000.0,"PaymentsToAcquireShortTermInvestments_2_Q2_USD":27652000.0,"LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_0_Q2_USD":14000.0,"LessorOperatingLeasePaymentsToBeReceived_0_Q2_USD":55000.0,"AccountsReceivableNetCurrent_0_Q2_USD":367000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-2546000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":17527000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":8578000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":807000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":0.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-9875000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-20341000.0,"OtherAssetsNoncurrent_0_Q2_USD":26000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-809000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":2302000.0,"OperatingLeaseLiability_0_Q2_USD":2491000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"EquitySecuritiesFvNiGainLoss_2_Q2_USD":0.0,"DebtSecuritiesCurrent_0_Q2_USD":42449000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":6315000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":3110000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":61892407.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":62042778.0,"AccruedLiabilitiesCurrent_0_Q2_USD":4811000.0,"PreferredStockValueOutstanding_0_Q2_USD":0.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_2_Q2_USD":-43000.0,"Liabilities_0_Q2_USD":8538000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":3196000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"OperatingIncomeLoss_2_Q2_USD":-21199000.0,"InterestIncomeExpenseNet_1_Q2_USD":270000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1391000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-18694000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":42449000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":191000.0,"LiabilitiesCurrent_0_Q2_USD":6236000.0,"AccountsPayableCurrent_0_Q2_USD":1425000.0,"RestructuringReserveAccrualAdjustment1_1_Q2_USD":-5000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":53501000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":229000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":2578000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":578000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":804000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0828,"SubleaseIncome_2_Q2_USD":35000.0,"SubleaseIncome_1_Q2_USD":18000.0,"AdditionalPaidInCapital_0_Q2_USD":782217000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q2_USD":0.0,"OperatingLeasePayments_2_Q2_USD":357000.0,"OperatingLeasePayments_1_Q2_USD":180000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":338000.0,"NetIncomeLoss_2_Q2_USD":-20436000.0,"InterestIncomeExpenseNet_2_Q2_USD":763000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":130000.0,"CommonStockSharesOutstanding_0_Q2_shares":62172418.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-866000.0,"OperatingIncomeLoss_1_Q2_USD":-10286000.0,"RestructuringReserve_0_Q2_USD":14000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":101673000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":2717000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":1391000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":189000.0,"OperatingExpenses_2_Q2_USD":23842000.0,"OperatingExpenses_1_Q2_USD":11688000.0,"LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_0_Q2_USD":41000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.33,"CommonStockValueOutstanding_0_Q2_USD":62000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.16,"StockholdersEquity_0_Q2_USD":93135000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":11000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":42319000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":277000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_2_Q2_USD":80652000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":2643000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":1402000.0,"StockIssuedDuringPeriodSharesRestrictedStockAwardGross_2_Q2_shares":163000.0,"StockIssuedDuringPeriodSharesRestrictedStockAwardGross_1_Q2_shares":0.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-689274000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":36600000.0,"ProfitLoss_1_Q2_USD":-10016000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":362000.0,"Ticker":"CMRX","CIK":"1117480","name":"CHIMERIX INC","OfficialName":"Chimerix Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"418603126.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]